![Domenick P. Treschitta](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Domenick P. Treschitta
Direktor/Vorstandsmitglied bei Ash Access Technology, Inc.
Aktive Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Robert Truitt | M | - |
Ash Access Technology, Inc.
![]() Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | 41 Jahre |
Stephen R. Ash | M | 78 |
Ash Access Technology, Inc.
![]() Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | 41 Jahre |
Nels P. Bergmark | M | - |
Ash Access Technology, Inc.
![]() Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | 32 Jahre |
Norman R. Weldon | M | - |
Ash Access Technology, Inc.
![]() Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | - |
Gary Lehman | M | 71 |
Ash Access Technology, Inc.
![]() Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | - |
Lorelei D. Davis | M | - |
Ash Access Technology, Inc.
![]() Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | - |
Daniel J. Olson | M | - |
Ash Access Technology, Inc.
![]() Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | 19 Jahre |
Joseph H. Broecker | M | - |
Ash Access Technology, Inc.
![]() Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | - |
Adel B. Korkor | M | - |
Ash Access Technology, Inc.
![]() Ash Access Technology, Inc. Medical SpecialtiesHealth Technology Ash Access Technology, Inc. develops catheters, antimicrobials, vascular access devices and other catheter-related products and services. Its products include zuragen Injection, zuraprep, centros and pipeline. The firm engages in the development and commercialization of proprietary technologies and devices to treat and prevent the clinical consequences of diseases and disorders related to vascular access. The company was founded by Robert B. Truitt and Stephen R. Ash in 1983 and is headquartered in Lafayette, IN. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Robert A. Lerman | M | 89 |
University of Connecticut
| 1 Jahre |
Mark Ronald Shenkman | M | 81 |
University of Connecticut
| 4 Jahre |
Dave L. Anderson | M | 79 |
University of Connecticut
| 4 Jahre |
Ira S. Loss | M | - |
University of Connecticut
| 4 Jahre |
Kevin J. Dunne | M | - |
University of Connecticut
| 4 Jahre |
Gary F. Derbenwick | M | - |
University of Connecticut
| 4 Jahre |
Bill F. Dausch | M | - |
University of Connecticut
| 4 Jahre |
Patrick J. Sheehan | M | 77 |
University of Connecticut
| 4 Jahre |
John Orabona | M | - |
University of Connecticut
| 4 Jahre |
Anthony J. Esposito | M | - |
University of Connecticut
| 4 Jahre |
Francis A. Reed | M | - |
University of Connecticut
| 4 Jahre |
John Anthony Beirne | M | - |
University of Connecticut
| 4 Jahre |
Statistik
Land | Beziehungen | % des Gesamten |
---|---|---|
Vereinigte Staaten | 21 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Domenick P. Treschitta
- Persönliches Netzwerk